NABP and Pfizer Partner to Educate Patients About The Flood of Counterfeit Medicines Online

PfizerPfizer Inc. (NYSE: PFE) and the National Association of Boards of Pharmacy® (NABP) are launching a new effort to draw attention to the risks associated with counterfeit prescription medicines and help patients learn how to safely buy medicines online. Prescription medicines are among the most counterfeited consumer goods. Worldwide sales of counterfeit medicines were estimated to exceed $75 billion last year - an increase of 90 percent since 2005. Last year, one in six Americans purchased medicines on the Internet, potentially exposing them to harmful counterfeits.

Exposure to counterfeit medicines can have serious consequences, either because they include dangerous substances such as rat poison and lead paint or because they do not include the correct, U.S. Food and Drug Administration (FDA)-approved amount of active pharmaceutical ingredient, which means patients may not get the intended therapeutic benefit.

"Authentic prescription medicines are manufactured with pure ingredients in clean facilities, under a highly-regulated, quality-controlled process, but counterfeit medicines are often produced in unsanitary conditions by people without any medical or scientific background," said Patrick Ford, senior director global security, Americas region, Pfizer. "Law-enforcement officials have found fake medicines being made in bathrooms and outdoors in the vicinity of farm animals."

In 2010, U.S. Department of Homeland Security Customs and Border Protection seized 170 percent more illegal pharmaceutical products ($5.6 million) than in 2005 ($2.1 million). Despite diligent work by U.S. law enforcement, it is unknown how many more millions of dollars of counterfeit medicines are circulating online. A recent review by NABP of more than 8,000 websites selling prescription medicines found that 96 percent appeared to be operating in conflict with pharmacy laws and practice standards, putting patients at risk of receiving counterfeit or adulterated medicines.

"Counterfeiters who sell fake medicines online prey on ingrained online buying behavior, in which consumers disregard warning signs, and prioritize price and convenience," said Carmen Catizone, M.S., R.Ph., D.Ph., executive director, NABP. "As a result, counterfeiters sell fake medicines through deceptive practices and typically don't insist that patients provide a valid prescription, which is required by law."

Adding to the danger, patients who buy medicines from illegitimate online pharmacies are at risk of financial fraud and identity theft when they share their credit card and other personal information with criminal counterfeiting networks.

Consumers Find It Difficult to Detect Real vs. Fake Medicines Online
All types of medicines - brand-name, over-the-counter and generic - can be and have been counterfeited, including medicines for cancer, high cholesterol, hypertension, allergies, infections and pain management. Pfizer has confirmed the presence of counterfeit Pfizer medicines in at least 101 countries. Pfizer's Viagra® (sildenafil citrate) tablets are among the most commonly counterfeited medicines. In addition to counterfeits, patients who order Viagra online may receive a product labeled "generic Viagra" that is not manufactured by Pfizer and has not been approved by the FDA.

In a new Harris Interactive survey conducted by Pfizer, men with erectile dysfunction (ED) were confused about whether ED medicines sold online were authentic and whether the websites selling medicines online were legitimate pharmacies.

Even though only a very small percentage (six percent) of men surveyed considered themselves extremely or very knowledgeable about determining the legitimacy of an online pharmacy, many men were still likely to engage in risky online buying behaviors, such as buying ED medicines from online pharmacies advertised by spam (27 percent) or based on an online search (36 percent). The survey also found that nearly half of men (49 percent) accurately believe that not all online pharmacies are regulated by the government. State boards of pharmacy, not the federal government, regulate legitimate online pharmacies; fake online pharmacies are not regulated at all.

In a separate analysis, Pfizer purchased and tested Viagra from 26 pharmacy websites that appeared in the top results for "buy Viagra" on two major search engines. Pfizer found that all analyzed pharmacies claiming to sell Viagra were operating illegally and 81 percent were selling counterfeit Viagra.

Another common tactic that counterfeiters use to mislead U.S.-based consumers is to represent themselves as being based in Canada. In the Harris Interactive survey, men were more likely to trust websites claiming to be based in Canada that sell ED medicines (46 percent) than websites based in countries other than the U.S. or Canada (23 percent). However, the analysis conducted by Pfizer showed that none of the four sites promoting themselves as "Canadian pharmacies" actually shipped their products from Canada; instead, products were shipped from Hong Kong, India and the U.S. The Harris Interactive survey also found that even though one in four men (23 percent) did not believe that online pharmacies claiming to be based in Canada are selling real brand-name products, nearly half of men (46 percent) would still consider buying ED medicines from them.

"Counterfeiters have good reason to fool patients into buying fake medicines online," said Mr. Ford. "They have no consideration whatsoever for patient health and safety, and the risks of prosecution are lower than those associated with selling illegal drugs. Counterfeiters are adept at producing fake medicines that look authentic and developing websites that look like legitimate online pharmacies. Consumers, though, can outsmart counterfeiters, as long as they know what to look for."

Help For Consumers Wanting to Buy Authentic Prescription Medicines Online
Consumers in the U.S. who opt to shop online for medicine can do so safely. The FDA advises that websites with NABP's Verified Internet Pharmacy Practice Sites® (VIPPS) seal are licensed pharmacies from which patients can purchase FDA-approved medicines. A list of U.S.-based online pharmacies with VIPPS accreditation can be found at www.VIPPSpharmacies.net.

Consumers who suspect that they have purchased a counterfeit prescription medicine should contact their physician and the FDA's MedWatch program by phone at 1-800-332-1088 or online at www.fda.gov/MedWatch. Those who suspect they have purchased a counterfeit Pfizer product are also encouraged to call 1-800-438-1985.

Pfizer and NABP's new educational effort will draw attention to the risks of buying counterfeit medicines and help consumers find legitimate online pharmacies. The campaign will use five channels to reach consumers online:

  • A new YouTube channel offers a video series that features experts from Pfizer, NABP, Microsoft and McAfee, a company dedicated to protecting consumers online. The video series can be found at www.youtube.com/spotfakemeds.
  • The NABP website, www.AWARERx.org, offers consumers easy-to-understand information about the dangers of counterfeit medicines and tips on how to select an online pharmacy from which to safely buy medicine.
  • The Viagra website, www.Viagra.com, includes additional patient-education resources, including the "Anatomy of a Fake Website" and the "Spot the Fake" quiz, which educate patients on the gimmicks counterfeiters use to trick them into buying fake medicines.
  • Online advertising will reach patients at the critical moment when they are searching for popular keywords, such as "buy Viagra" and "cheap Viagra". When users click on Pfizer's ads, they will be taken to the Viagra YouTube channel to view educational videos about the dangers of counterfeit medicines and how to safely buy prescription medicines online.
  • Takeovers of websites once used by counterfeiters to sell fake Pfizer medicines will be implemented by Pfizer Global Security. To reach potential buyers, Pfizer will repopulate these sites with facts about the dangers of counterfeit medicines and ways to determine if online pharmacies are legitimate.

"We believe this joint effort with Pfizer will inform consumers about the dangers of counterfeit medicines and help them find legitimate websites and pharmacies licensed by the state boards of pharmacy that provide medicines approved by the FDA," said Mr. Catizone of the NABP. "Together, we hope to lessen the dangers related to purchasing medicines online."

Viagra is prescribed to treat erectile dysfunction (ED).

Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

About the National Association of Boards of Pharmacy (NABP)
NABP is the independent, international, and impartial Association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.

About the Harris Interactive Survey
A national survey of men with erectile dysfunction (ED) was conducted to better understand men’s online purchase patterns of ED medicines and knowledge about counterfeit medicines sold by online pharmacies. The survey, which included 1,000 men ages 35-74 in the United States, was fielded online between June 9 and June 15, 2011.

This press release has an accompanying Smart Marketing Page providing further details about the organization, products and services introduced above.

Most Popular Now

Novartis rises to second place in 2018 Access to M…

Novartis ranked second in the 2018 Access to Medicine Index (ATMi), up from 3rd place in 2016, in recognition of its long-standing efforts to improve worldwide access to ...

MSD is looking for a digital health solution to em…

MSD Lebanon is looking for an external partner to co-create a digital solution that helps oncologists to stay updated with relevant clinical content about cancer. The sol...

Lilly submits New Drug Application to the FDA for …

Eli Lilly and Company (NYSE: LLY) has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lasmiditan for the acute...

FDA approves new treatment for patients with acute…

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for t...

New study reveals probiotics do not help children …

Probiotics are a multibillion-dollar industry with marketing claims of being an effective treatment for a multitude of ailments, including diarrhea. However, findings fro...

Sanofi builds focus on rare blood disorders and ca…

Some of the most serious unmet patient needs today are in the field of hematology. Rare blood disorders and blood-related cancers continue to be a major focus of research...

Merck and Pfizer provide update on avelumab in pla…

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxor...

Bristol-Myers Squibb awards "Golden Tickets…

Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, today anno...

U.S. FDA approves Larotrectinib, the first TRK inh…

The U.S. Food and Drug Administration (FDA) has approved larotrectinib, the first oral TRK inhibitor, under the brand name Vitrakvi®. The approval is for the treatment of...

Scorpion venom to shuttle drugs into the brain

The Peptides and Proteins lab at the Institute for Research in Biomedicine (IRB Barcelona) has published a paper in Chemical Communications describing the capacity of a s...

Abbott recommends rejection of below-market mini-T…

Abbott (NYSE: ABT) received notice of an unsolicited mini-tender offer by Baker Mills LLC (Baker Mills) to purchase up to 60,000 Abbott common shares, representing approx...

AstraZeneca to divest US Synagis rights to Sobi

AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncyt...